PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE HCV NS5A INHIBITOR ABT-267 FOLLOWING SINGLE AND MULTIPLE DOSES IN HEALTHY ADULT VOLUNTEERS

被引：14
|
作者：
Dumas, E. O. [1 ]
Lawal, A. [1 ]
Menon, R. M. [1 ]
Podsadecki, T. [1 ]
Awni, W. [1 ]
Dutta, S. [1 ]
Williams, L. [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61206-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1204
引用
收藏
页码：S475 / S476
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects
    Shirae, Shinichiro
    Ose, Atsushi
    Kumagai, Yuji
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (06): : 744 - 753
  • [32] No Pharmacokinetic Interaction Between HCV NS5A Inhibitor Elbasvir and Buprenorphine/Naloxone in Healthy Volunteers
    Marshall, William L.
    Marenco, Ted
    Feng, Hwa-Ping
    Barbour, April M.
    Gilmartin, Jocelyn
    Liu, Fang
    Panebianco, Deborah L.
    Mirzac, Angela
    Di Spirito, Mike
    Stypinski, Daria
    Machnes, Ziv
    Gartner, Michael
    Iwamoto, Marian
    Butterton, Joan R.
    Yeh, Wendy W.
    HEPATOLOGY, 2015, 62 : 573A - 573A
  • [33] Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses
    Moore, KHP
    Hussey, EK
    Shaw, S
    Fuseau, E
    Duquesnoy, C
    Pakes, GE
    CEPHALALGIA, 1997, 17 (04) : 541 - 550
  • [34] ANTIVIRAL ACTIVITY, PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PSI-7851, A NOVEL NUCLEOTIDE POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE AND 3 DAY MULTIPLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC HCV INFECTION
    Rodriguez-Torres, Maribel
    Lawitz, Eric
    Flach, Stephen
    Denning, Jill M.
    Albanis, Efsevia
    Symonds, William
    Berrey, M. M.
    HEPATOLOGY, 2009, 50 (06) : 11A - 11A
  • [35] Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein™) in healthy volunteers
    Ullmann, U
    Metzner, J
    Frank, T
    Cohn, W
    Riegger, C
    ADVANCES IN THERAPY, 2005, 22 (01) : 65 - 78
  • [36] Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein™) in healthy volunteers
    Uwe Ullmann
    Juergen Metzner
    Thomas Frank
    William Cohn
    Christoph Riegger
    Advances in Therapy, 2005, 22 : 65 - 78
  • [37] Population Pharmacokinetics of a Pangenetic NS5A inhibitor, ABT-530, in HCV infected Patients with and without Cirrhosis
    Lin, Chih-Wei
    Jones, Aksana Kaefer
    Liu, Wei
    Dutta, Sandeep
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S86 - S86
  • [38] Safety, Tolerability, and Pharmacokinetics of Eliglustat Tartrate (Genz-112638) After Single Doses, Multiple Doses, and Food in Healthy Volunteers
    Peterschmitt, M. Judith
    Burke, Amy
    Blankstein, Larry
    Smith, Sharon E.
    Puga, Ana Cristina
    Kramer, William G.
    Harris, James A.
    Mathews, David
    Bonate, Peter L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 695 - 705
  • [39] Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers
    Liu, Jian
    Zhai, You
    Wu, Lihua
    Wu, Guolan
    Zheng, Yunliang
    Hu, Xingjiang
    Shentu, Jianzhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 613 - 620
  • [40] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RG1678, A NOVEL GLYCINE REUPTAKE INHIBITOR, AFTER MULTIPLE DOSES IN HEALTHY VOLUNTEERS
    Martin-Facklam, Meret
    Patat, Alain
    Hofmann, Carsten
    Boetsch, Christophe
    Banken, Ludger
    Biedinger, Ursula
    Boutouyrie-Dumont, Bruno
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S267 - S267
12345